RECRUITING

Deep Brain Stimulation (DBS) Retrospective Outcomes Study

Talk to us

Conditions

Parkinson DiseaseEssential TremorDystonia

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The primary objective of this study is to characterize real-world clinical outcomes of Deep Brain Stimulation (DBS) using retrospective review of de-identified patient records.

Official Title

Deep Brain Stimulation (DBS) Retrospective Outcomes Study

Quick Facts

Study Start:2019-03-12
Study Completion:2028-12
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT03664609

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:Not specified
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:CHILD, ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Must be previously treated with or eligible for implantation with a deep brain stimulation system
  1. * No Exclusion Criteria

Contacts and Locations

Study Contact

Cleo Mertz
CONTACT
855-213-9890
BSNClinicalTrials@bsci.com
Diane Keesey
CONTACT
855-213-9890
BSNClinicalTrials@bsci.com

Principal Investigator

Natalie Bloom Lyons
STUDY_DIRECTOR
Boston Scientific Neuromodulation Corporation

Study Locations (Sites)

St. Joseph's Hospital & Medical Center
Phoenix, Arizona, 85013
United States
University of California, San Francisco
San Francisco, California, 94143
United States
University of Miami Hospital
Miami, Florida, 33136
United States
University of South Florida
Tampa, Florida, 33612
United States
St. Luke's Regional Medical Center
Boise, Idaho, 83712
United States
Albany Medical Center
Albany, New York, 12208
United States
Wake Forest University School of Medicine
Winston-Salem, North Carolina, 27157
United States
Allegheny General Hospital
Pittsburgh, Pennsylvania, 15212
United States
Swedish Neuroscience Institute
Seattle, Washington, 98122
United States

Collaborators and Investigators

Sponsor: Boston Scientific Corporation

  • Natalie Bloom Lyons, STUDY_DIRECTOR, Boston Scientific Neuromodulation Corporation

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2019-03-12
Study Completion Date2028-12

Study Record Updates

Study Start Date2019-03-12
Study Completion Date2028-12

Terms related to this study

Additional Relevant MeSH Terms

  • Parkinson Disease
  • Essential Tremor
  • Dystonia